A trial of traditional Chinese medicine for ALS with high sphingolipids
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether a traditional Chinese medicine made from Cordyceps cicadae can help people with ALS who have high levels of certain fats (sphingolipids) in their blood. It may offer a new treatment option for those diagnosed recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ALS, confirmed by a neurologist
- Your blood test shows high levels of certain fats called sphingolipids
- You were diagnosed with ALS within the last 2 years
- You are between 18 and 80 years old and not pregnant
- If you take riluzole or edaravone, your dose has been the same for at least 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding two supplements (EH-301 and N-acetylcysteine) to the standard ALS medicine Riluzole can help slow the disease. It is for people diagnosed with ALS within the last 18 months who still have good breathing and daily function.
This trial tests a very high-calorie, fatty diet to see if it helps people with ALS. If you have been diagnosed recently and are not too advanced in the disease, this special diet may give your body extra energy to slow progression.
This study tests a supplement called acetyl-L-carnitine (ALCAR) to see if it can slow the progression of ALS. It is for people in the early stages of the disease who are already taking riluzole and have good lung and muscle function.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This trial tests a new treatment aimed at restoring the function of a gene called UNC13A in people with ALS. It involves multiple clinic visits, MRI scans, and spinal taps to see if the treatment is safe and may slow the disease.
This trial tests an experimental drug called MRG-001 for people with amyotrophic lateral sclerosis (ALS). It aims to see if the drug can help slow the progression of the disease.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.